Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: Potential diagnostic pitfalls using myoepithelial markers

Modern Pathology

Volumn 19, Issue 10, 2006, Pages 1351-1357

  Rabban, Joseph T ^a   Swain, Rebecca S ^a   Zaloudek, Charles J ^a   Chase, Donald R ^b   Chen, Yunn Yi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Tumor Tissue Registry   (United States)

Author keywords

Adenoid cystic carcinoma; Breast; CD117; Collagenous; Myoepithelium; p63; Spherulosis

Indexed keywords

ALPHA ACTIN; CALPONIN; MYOSIN HEAVY CHAIN; PROTEIN P63; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ARTICLE; BREAST DISEASE; CLINICAL ARTICLE; COLLAGENOUS SPHERULOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 33748871006     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800658     Document Type: Article

References (30)

1. Mastropasqua MG, Maiorano E, Pruneri G, et al. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol 2005;18:1277-1282.
2. Crisi GM, Marconi SA, Makari-Judson G, et al. Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol 2005;124:733-739.
3. Azoulay S, Lae M, Freneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol 2005;18:1623-1631.
4. Trendell-Smith NJ, Peston D, Shousha S. Adenoid cystic carcinoma of the breast: a tumour commonly devoid of oestrogen receptors and related proteins. Histopathology 1999;35:241-248.
5. Zaloudek C, Oertel YC, Orenstein JM. Adenoid cystic carcinoma of the breast. Am J Clin Pathol 1984;81: 297-307.
6. Peters GN, Wolff M. Adenoid cystic carcinoma of the breast. Report of 11 new cases: review of the literature and discussion of biological behavior. Cancer 1983; 52:680-686.
7. Ulivi P, Zoli W, Medri L, et al. c-kit and SCF expression in normal and tumor breast tissue. Breast Cancer Res Treat 2004;83:33-42.
8. Hill PA. c-kit expression in adenoid cystic carcinoma of the breast. Pathology 2004;36:362-364.
9. Clement PB, Young RH, Azzopardi JG. Collagenous spherulosis of the breast. Am J Surg Pathol 1987;11: 411-417.
10. Resetkova E, Albarracin C, Sneige N. Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature. Am J Surg Pathol 2006; 30:20-27.
11. Mooney EE, Kayani N, Tavassoli FA. Spherulosis of the breast. A spectrum of municous and collagenous lesions. Arch Pathol Lab Med 1999;123: 626-630.
12. Kleer CG, Oberman HA. Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity. Am J Surg Pathol 1998;22:569-575.
13. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
14. Yared MA, Middleton LP, Meric F, et al. Expression of c-kit proto-oncogene product in breast tissue. Breast J 2004;10:323-327.
15. Newman Dorland WA (ed). Dorland's Illustrated Medical Dictionary, 28th edn. WB Saunders Company: Philadelphia, 1994.
16. Schultz-Brauns O. Die Geschwulste der brustdruse. In: Lubarsch O, Henke F (eds). Handbuch der Speziellen Pathologischen Anatomie und Histologie, Vol. VII. Verag Von Julius Springer: Berlin, 1933, pp 290-292.
17. Rosen PP. Breast Pathology. Lippincott Williams & Wilkins: Philadelphia, 2001, p 273.
18. Lamovec J, Us-Krasovec M, Zidar A, et al. Adenoid cystic carcinoma of the breast: a histologic, cytologic, and immunohistochemical study. Semin Diagn Pathol 1989;6:153-164.
19. Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol 1987;18:1276-1281.
20. Anthony PP, James PD. Adenoid cystic carcinoma of the breast: prevalence, diagnostic criteria, and histogenesis. J Clin Pathol 1975;28:647-655.
21. Qizilbash AH, Patterson MC, Oliveira KF. Adenoid cystic carcinoma of the breast. Light and electron microscopy and a brief review of the literature. Arch Pathol Lab Med 1977;101:302-306.
22. Friedman BA, Oberman HA. Adenoid cystic carcinoma of the breast. Am J Clin Pathol 1970;54:1-14.
23. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 2003;16:1224-1231.
24. Edwards PC, Bhuiya T, Kelsch RD. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:586-593.
25. Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:613-619.
26. Diallo R, Rody A, Jackisch C, et al. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu. Hum Pathol 2006;37:205-211.
27. Tsuda H, Morita D, Kimura M, et al. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation. Cancer Sci 2005;96:48-53.
28. Lazard D, Sastre X, Frid MG, et al. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993; 90:999-1003.
29. Wang NP, Wan BC, Skelly M. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and in situ carcinoma from invasive carcinoma of the breast. Appl Immunohistochem 1997; 5:141-151.
30. Werling RW, Hwang H, Yaziji H, et al. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 vs calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 2003;27:82-90.